News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Finance
Swiss Biopharma Cardiorentis Enters Euro 45 Million Financing Deal 9/17/2014
Avraham Pharmaceuticals Ltd. Raises $4.5 Million In Additional Investment Led By Yissum 9/17/2014
MGB Biopharma Limited Secures $6.4 MillionTo Advance Its Novel Lead Antibacterial, MGB-BP-3, Into Clinical Development 9/17/2014
Qu Biologics Closes Oversubscribed Private Funding Round Of CDN$5.1 Million 9/17/2014
New York Blood Center Receives $2 Million In NIDA Funding To Develop HIV Self-Testing Intervention 9/16/2014
Cambridge, Mass.-Based Biotech Startup Scholar Rock Reels In $20 Million 9/16/2014
Parion Sciences Announces $3 Million Award From Cystic Fibrosis Foundation Therapeutics, Inc. To Accelerate The Development Of Novel CF Treatment 9/16/2014
Jeffrey Modell Foundation Awards $1 Million For Translational Research 9/16/2014
Molecular Templates Inc. Announces Completion Of $12 Million Series C Financing 9/15/2014
Bay Area's Cellerant Therapeutics, Inc. Awarded $47.5 Million From The U.S. Government 9/11/2014
Prostate Cancer Foundation Awards $6.1 Million To 2014 Young Investigators, Jumpstarting Careers Of Promising MDs And PhDs 9/11/2014
AM-Pharma Holding BV Locks In €12.2 Million Financing Round 9/11/2014
Serial Biotech Exec Christoph Westphal Banks $40 Million For Startup FlexPharma 9/10/2014
New Jersey's Aerie Pharmaceuticals, Inc. (AERI) Grabs $125 Million Financing Commitment 9/10/2014
VC Firm OrbiMed Advisors Raises $325 Million For Second Asia Healthcare Fund 9/10/2014
Airway Therapeutics, LLC Raises $4.6 Million In Series A Funding 9/10/2014
Stanford StartX & Mission Bay Capital Invest $1.86 Million In University of California, Berkeley (CAL) Spin-out For Single Cell Analysis 9/10/2014
Bill & Melinda Gates Foundation Commits $50 Million To Support Emergency Response To Ebola 9/10/2014
Euclises Pharmaceuticals Announces Series A Financing 9/9/2014
Poxel Nails $13.5 Million From New Investors 9/9/2014
F2G Ltd, The UK-Based Antifungal Drug Discovery And Development Company, Today Announced A Major Funding Award From The Technology Strategy Board’s Biomedical Catalyst 9/9/2014
SGB Makes Breakthrough With New Hybrid Jatropha, Closes $11M Series C financing 9/9/2014
Edge Therapeutics Grabs $10 Million Venture Loan 9/8/2014
NanoViricides, Inc. (NNVC.PK) Raises Approximately $7.5 Million Upon Exercise Of Certain Old Warrants By Its Long Standing Investors 9/8/2014
Sonendo Closes $35 Million Equity Financing Round 9/8/2014
Centers for Disease Control and Prevention (CDC) Awards $7.5 Million To Expand The National Violent Death Reporting System To 32 States 9/8/2014
VC Firm Targeted Technology Secures $40 Million+ Geared Towards Early-Stage Biotechs 9/5/2014
Oncore Closes Series R Financing 9/5/2014
Bionomics Limited (BNO.AX) Receives $7.5M 2014 R&D Tax Incentive 9/5/2014
iSpecimen Closes $8 Million In Financing 9/4/2014
Feds To Provide As Much As $42.3 Million To Tiny San Diego-Based Mapp Biopharmaceutical 9/3/2014
BioGenerator And Cultivation Capital Lead $1.8 Million Investment Round For Immunophotonics 9/3/2014
GC-Rise Locks In $15 Million 9/2/2014
Clearside Biomedical Snags $16 Million Series B Financing 9/2/2014
WaferGen Biosystems Announces Successful Completion Of Public Offering Raising $20 Million 8/28/2014
Boston Startup OncoPep Secures $6.9 Million Series B Financing 8/28/2014
Menlo Park Startup Armetheon Snags $7 Million Series A Financing 8/28/2014
Fresh From Co-Founding Massively Financed Juno Therapeutics, Arch Venture Partners Banks $400 Million+ To Back New Biotechs 8/27/2014
Zai Lab Of Shanghai Raises Over $30 Million In Series A Funding 8/27/2014
Houston Biotech Bellicum Pharmaceuticals, Inc. Nabs $55 Million 8/27/2014
Vaccinogen Plans Move To Baltimore After $80 Million In New Funding; Will Increase Headcount By 300 Percent 8/27/2014
Redwood City Startup, Aldea Pharmaceuticals, Reels In $24 Million 8/26/2014
Massachusetts' Civitas Therapeutics Locks In $55 Million 8/26/2014
NEOMED Receives $12 Million From Federal Government 8/26/2014
Viropro Inc. (VPRO) Initiates Interim Debt Financing Of Up To $500,000 8/26/2014
FortuneRock (China) Hauls In $24 Million 8/25/2014
Heat Biologics Closes On Up To $7.5 Million Secured Term Loan Facility 8/25/2014
Vaccinogen Completes Initial Closing Of An $80 Million Financing 8/25/2014
NeuroDerm Ltd. Banks $16 Million 8/22/2014
Sprout Pharmaceuticals Eyes $15 Million From Private Investors To Develop Female Viagra 8/22/2014
Emisphere Technologies, Inc. (EMIS) Announces $20 Million Debt Financing to Launch Oral Eligen® B12 8/20/2014
Redwood City's Dermira Bags $51 Million, Expands Management Team And Board 8/20/2014
Bay Area's HealthQuest Capital Bags $110 Million For Debut Fund With Healthcare, Medtech Focus 8/19/2014
Redwood City's Comprehend Systems Bags $21 Million Series B Funding 8/18/2014
Switzerland-Based Santhera Pharmaceuticals AG (SANN.SW) Grabs CHF 13.4 Million 8/15/2014
Struggling Dendreon Corporation (DNDN) Plunges After Warning Investors Of Debt Woes 8/14/2014
Novartis AG (NVS), Siemens (SI), And Laboratory Corporation of America Holdings (LabCorp) (LH) Dumps $16 Million Into Seventh Sense Biosystems Inc. 8/13/2014
Tarsa Therapeutics Secures $10 Million, Adds Industry Veteran As A Director 8/13/2014
G2B Pharma Receives Project Financing From Sosei Group Corporation And Right To In-License Nasal Delivery Technologies From SNBL 8/13/2014
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of BCX4430 To Treat Hemorrhagic Fever Virus Diseases 8/13/2014
Ortenzio Foundation & Select Medical (SLMC) Gift $1.25M To Kessler Foundation Neuroimaging & Rehab Research 8/13/2014
Public Health Agency of Canada Release: Government Of Canada Donates Experimental Ebola Vaccine To World Health Organization 8/13/2014
Synergy Healthcare plc (SYR) Invests 18 Million Gbp (Us$30 Million) To Expand Global Applied Sterilisation Technology Capacity 8/13/2014
Acupera Raises Additional $4 Million for Population Health Platform 8/12/2014
Novogen Limited (NVGN) Receives Funding Support To Commence Studies In Muscular Dystrophy 8/12/2014
GenoSpace Announces Strategic Investment by Thomson Reuters 8/12/2014
Sirona (SIRO) Subsidiary, TFChem, Receives CDN$1.2 Million For Anti-Aging Project 8/12/2014
TapImmune Inc. (TPIV) Announces $2 Million Registered Direct Offering 8/11/2014
FAAH Pharma Inc. Announces Investment From TVM Life Science Ventures VII To Develop New Treatment Against Neuropathic Pain 8/11/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Scores $5.4 Million Private Financing 8/8/2014
Tolero Pharmaceuticals Bags $14.2 Million Series B Financing 8/8/2014
Innovus Pharma Secures Additional Funding By Increasing Its Line Of Credit With Its Chief Executive Officer To $1.5 Million, Provides Quarter Update And Timing Of Its 10-Q Filing 8/6/2014
Already-Rich Juno Therapeutics Reels In Another $134 Million, Has Raised $300 Million In Less Than 12 Months 8/6/2014
Menlo Park's TesoRx Locks In $10 Million, Secures Key Patent And Taps Renowned Urologist As Chief Medical Officer 8/5/2014
Perlstein Lab Raises $2 Million For Orphan Drug Discovery 8/5/2014
IP Group Plc - Portfolio Company Diurnal Announces £6 Million Funding Round 8/5/2014
Biotech Startup Rebiotix Nabs $25 Million Series B 8/4/2014
National Cancer Institute Awards $7.3 Million To Kaiser Permanente For Cancer Clinical Trials, Patient Care Research 8/4/2014
Metabolix, Inc. Enters Into Private Placement Agreement With Investors To Raise $25 Million In Equity Financing 8/4/2014
GE Foundation Announces $20 Million Commitment To Maternal And Child Health Programs In Africa 8/4/2014
GliaCure Closes On $5.8 Million Financing 8/4/2014
VC Firm Venrock Locks In $450 Million To Invest In Tech And Life Sciences Startups 8/1/2014
Celladon Corporation Secures $25 Million Credit Facility From Hercules Growth Capital 8/1/2014
SoCal Biopharma Cold Genesys, Inc. Locks In $13.57 Million Series A 7/31/2014
Cambridge-Based Gen9 Gets $25 Million In Equity Funding For DNA Synthesis 7/31/2014
Lazarus Effect Closes $5 Million Financing 7/31/2014
Lightlake Therapeutics Inc. (LLTP) Receives Funding Commitment From A Prominent International Research And Development Foundation 7/30/2014
Axxess Pharma, Inc. Secures $2 Million USD In Financing To Fulfill Increased Rate Of Purchase Orders 7/30/2014
Big Pharmas Such As Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Pitch In On $51.1 Million Fund For New York City And Seattle Biotechs 7/29/2014
Four Biotech-Related Companies Sign Up For Start-Up NY Program, New Jobs Created 7/29/2014
Amedisys (AMED) Announces New $70 Million Second Lien Credit Facility And Amendment To Senior Secured Credit Facility 7/29/2014
Biodel Inc. (BIOD) Enters Into $15 Million Equity Commitment With Lincoln Park Capital 7/28/2014
Oxford Finance Closes $8 Million Senior Debt Facility With Natrix Separations, Inc. 7/28/2014
Oregon Health & Science University (OHSU) Knight Cancer Challenge Attracts $100 Million Gift 7/28/2014
Bay Area's PaxVax, Inc. Reels In Up To $60 Million Financing 7/28/2014
New Cambridge-Based Biotech VC Firm Remiges BioPharma Emerges, Eyes $150 Million Fund 7/25/2014
Glaucoma Research Foundation Receives $1 Million Bequest From San Francisco Philanthropist Paul S. May 7/25/2014
Theraclion Receives €900 Thousand From Bpifrance's "Industrial Strategic Innovation" Program To Fund Development Of A New Treatment System In Collaboration With Supersonic Imagine 7/25/2014
Xention Limited Awarded £1.4m From Technology Strategy Board To Develop New Medicines For Atrial Fibrillation 7/24/2014
Atox Bio Locks In $23 Million 7/24/2014
Cambridge-Based Broad Institute To Receive Largest Gift Worldwide: $650 Million 7/23/2014
Mela Sciences (MELA) Announces $27.3 Million Private Placement Of Preferred Stock, Debentures And Warrants 7/23/2014
Taiho Pharmaceutical Invests US $30 Million In Remiges Biopharma Fund, LP 7/23/2014
Synlogic Secures $29.4 Million Series A Financing Led By Atlas Venture 7/22/2014
Skystar Bio-Pharmaceutical (CGPN) Of Xi’an Raises $5 Million 7/22/2014
Phosphagenics Limited (POH.AX) Completes First Tranche of A $19.3 Million Capital Raising 7/21/2014
Cerecor Inc. Closes On Initial Tranche Of US $32 Million Series B Financing 7/21/2014
StemCells Inc. (STEM) Announces Closing Of $20 Million Offering 7/21/2014
UrgentRx® Locks In $17.5 Million In Series C Funding 7/17/2014
Infosys Co-founder Kris Gopalakrishnan Donates $1.8 Million To Carnegie Mellon University To Promote Brain Research And Education 7/17/2014
InflaRx Announces Successful Closing Of Its Round B Financing 7/17/2014
Melanoma Research Foundation Release: Senate Appropriations Committee Increases Funding Available For Melanoma Research 7/17/2014
ZS Pharma (ZSPH) Secures $20 Million In Debt Financing 7/17/2014
Menlo Park's Virobay Inc. Completes $8 Million Series B Funding Round 7/16/2014
immatics biotechnologies GmbH Reels In €22 Million Series D 7/16/2014
Virobay Inc. Completes $8 Million Series B Preferred Stock Financing 7/16/2014
Phosphagenics Limited (POH.AX) Locks In $19.3 Million Capital Raising 7/11/2014
TONIX Pharmaceuticals, Inc. Announces Registered Direct Offering Of $7.8 Million 7/11/2014
Ocera Therapeutics, Inc. (OCRX) Raises $25.2 Million In Public Offering 7/10/2014
Fund Manager Dumps Biggest Investment Into AstraZeneca PLC (AZN) 7/9/2014
National Institutes of Health (NIH) Funds Phase 2 Clinical Trial At University of California, Los Angeles (UCLA) For The Treatment Of ADHD With NeuroSigma, Inc.'s eTNS Systemnational 7/9/2014
DelMar Pharmaceuticals Receives Funding From The Canadian Federal Government 7/9/2014
MabVax Therapeutics, Inc. Raises $3 Million In Common Stock Financing And An Additional $1.5 Million Upon Exercise Of Series C-1 Warrants 7/9/2014
480 Biomedical Awarded $1 Million Phase II NHLBI Contract To Advance Bioresorbable Scaffold For Pediatric Pulmonary Artery Stenosis 7/9/2014
Chromatin, Inc.Secures $12.5 Million Credit Facility With The PrivateBank 7/9/2014
Biosceptre International Limited Closes AUD 5 Million Financing From Existing Investors 7/9/2014
Domainex Ltd Reports Success Of Its Lead Compound In Pre-Clinical Model Of COPD And Secures £1.4 Million Biomedical Catalyst Award 7/9/2014
VC Firm Versant Ventures Closes In On $300 Million Fund For Medtech And Biotech 7/9/2014
Supernus Pharmaceuticals (SUPN) To Receive $30 Million In Non-Dilutive Royalty Deal 7/8/2014
New York Couple Gifts Cold Spring Harbor Laboratory $50 Million For Biology Center 7/7/2014
ProSensa Holding N.V. (RNA) Files F-3 SEC Mixed Shelf Registration For Up To $150 Million 7/7/2014
Galapagos NV (GLPG.BR) Raises €1.9 Million Through Warrant Exercises 7/7/2014
National Institutes of Health (NIH) Has A New $248 Million Focus: Electroceuticals 7/7/2014
Advanced Cell Technology Secures $30 Million Financing 7/3/2014
Akashi Therapeutics Receives Collective Funding Of $1.5 Million To Support HT-100 Clinical Development 7/3/2014
Zurex Pharma, Inc. Nabs $4 Million to Battle Hospital-Acquired Infections 7/3/2014
Retrophin, Inc. (RTRX) Snags $91 Million 7/2/2014
Novato's Raptor Pharmaceutical Inc. (RPTP) Reels In $70 Million 7/2/2014
Massachusetts Startup Synchroneuron Nets $20 Million To Fund SNC-102 For Neuropsychiatric Disorders 7/2/2014
Oxford Finance and Solar Capital Close $30 Million Senior Debt Facility With Radius (RDUS) 7/2/2014
TrovaGene, Inc. Secures $15 Million In Debt Financing From Trojantec Ltd. And Oxford Finance 7/1/2014
Sorrento Therapeutics, Inc. Awarded Up To $2.6 Million From The National Institutes of Health (NIH) For The Development Of New Anti-Bacterial Bispecific Antibodies And Antibody Formulated Drug Conjugates 7/1/2014
Karo Bio AB Granted 3.8 MSEK From Vinnova 7/1/2014
uniQure Secures Additional $10 Million Venture Loan From Hercules Capital 7/1/2014
AstraZeneca PLC (AZN) CEO Wagers $3.4 Million On Shares 7/1/2014
Menlo Park's Emerald Therapeutics Completes Latest Financing, Brings Total To $13.5 Million 7/1/2014
South San Francisco's Tobira Therapeutics Inc. Wraps Up $15 Million Loan Agreement 7/1/2014
Confirmed: With $32 Million, Boston Startup Morphs Into San Diego's Cidara Therapeutics 7/1/2014
Shire Gets $248 Million Tax Refund From Canada, More To Come 6/30/2014
To-BBB technologies BV Scrounges Up Euro 10 Million 6/30/2014
DURECT Corporation (DRRX) Secures $20 Million Debt Financing 6/27/2014
Biotech-Focused VC Firm Polaris Targets $400 Million For 7th Fund 6/27/2014
Actavis (ACT) Dumps $18 Million In New Warehouse Facilities 6/27/2014
SiEnergy Systems, LLC Awarded $2.65 Million As Part Of ARPA-E’s REBELS Program To Develop Innovative Distributed Generation Technologies 6/27/2014
Eighteen French Biotechs Such As Genticel And Genomic Vision Trek To New York To Hunt For American Investors 6/26/2014
Cytomedix Inc. (CMXI) Completes The Second Tranche Of The $35 Million Convertible Debt Financing With Deerfield Management Company 6/26/2014
Manchester's 4D Pharma Reels In $29 Million 6/26/2014
Biotech Fraud-Detection Firm BioCatch Bags $10 Million In Funding 6/26/2014
HedgePath Pharmaceuticals Secures Interim Financing To Commence Clinical Trials And Finalizes Key Agreement With Mayne Pharma Limited 6/25/2014
CrystalGenomics Nabs $12.8 Million From The Global Pharmaceutical Industry Development Fund 6/25/2014
Backed By New Investors Such As Lilly Ventures, Bay Area's Numerate Secures $8 Million 6/24/2014
TetraLogic Pharmaceuticals (TLOG) Announces Closing Of $47 Million Convertible Senior Notes Offering 6/24/2014
Transition Therapeutics Inc. (TTH.TO) Announces Closing Of Private Placement Equity Financing 6/23/2014
Oxitec Completes Oversubscribed £6.1 Million ($10.2 Million) Fundraising To Commercialise Pioneering Dengue Mosquito Control Technology 6/23/2014
Cambridge Startup Dimension Therapeutics Reels In $30 Million Financing 6/23/2014
Los Angeles' Genzum Life Sciences Reels In $20 Million In Funding 6/20/2014
Cambridge Startup Navitor Pharmaceuticals Debuts With $23.5 Million Series A In Pocket 6/20/2014
Dr. Reddy's Laboratories Ltd. (RDY) To Dump $320 Million In Biologics, Proprietary Medicines 6/20/2014
Sidney Kimmel Foundation Gives $110 Million To Jefferson Medical College Of Thomas Jefferson University 6/19/2014
Tyrogenex, Inc. Nabs $15 Million Series D Financing 6/19/2014
JHL Biotech Locks In $35 Million Series B Financing 6/19/2014
Horizon Biopharm In $300 Million Credit Agreement For Vidara Therapeutics Buy 6/19/2014
Western Oncolytics Receives $275,000 Seed Funding For Development Of Cancer Immunotherapy 6/18/2014
TetraLogic Pharmaceuticals (TLOG) Announces Pricing Of $47 Million Offering Of Convertible Notes 6/18/2014
Lakewood-Amedex Inc. Raises $5.5 Million In Series C Preferred Stock Financing 6/18/2014
Valeant Pharmaceuticals International (VRX) Commences Exchange Offer For Allergan Inc. (AGN) 6/18/2014
South San Francisco's True North Therapeutics Reels In $22 Million Series A Financing 6/18/2014
BioTime (BTX) Subsidiary Asterias Biotherapeutics Announces Investment By CEO 6/17/2014
BioTime (BTX) Subsidiary Asterias Biotherapeutics Raises $13.0 Million In Equity Financing 6/17/2014
AuraSense Therapeutics Completes $13.6 Million Series C Equity Investment 6/17/2014
Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million In Connection With Going Public Transaction 6/16/2014
BrainStorm Cell Therapeutics Inc. Raises $10.5 Million In Private Placement Financing 6/13/2014
CannLabs, Announces Reverse Merger And Commitment Of $1.25 Million In Funding 6/13/2014
Berkeley's Aduro Biotech Reels In $55 Million Series C Financing 6/13/2014
Health Integrated Secures $4 Million In Venture Debt Financing From Western Technology Investment 6/12/2014
Cortexyme Raises Seed Funding, Awarded Breakout Labs Investment 6/12/2014
Clarus Therapeutics Locks In $31.5 Million 6/12/2014
Merus Labs International Inc. Announces Aggregate $21 Million Financing Transactions 6/11/2014
BioSilta Completes EUR 2.5 Million ($3.4 Million) Funding Round 6/11/2014
Oxford Finance Closes $4 Million Debt Facility With IntelliCyt Corporation 6/11/2014
RuiYi (formerly Anaphore) Closes $4 Million Venture Loan From Silicon Valley Bank 6/11/2014
As Its Investors Reap Returns, San Francisco's Venbio Aims For A Bigger Second Fund 6/10/2014
Transition Therapeutics Inc. (TTH.TO) Enters Into Deal With Investors To Receive Up To $30.8 Million 6/6/2014
Nordic Nanovector Intends To Undertake Private Placement Of NOK 150 Million 6/6/2014
Cytori Therapeutics, Inc. (CYTX) Closes Previously Announced $10 Million Offering 6/6/2014
Its First Drug In Clinic, Kineta Inc. Keeps Raising Cash From Odd Sources 6/5/2014
“Grindeks” Invests 2.4 Million Euros In Quality Control Laboratory 6/5/2014
Complexa Wraps Up $13 Million Series B Financing Round 6/4/2014
SteadyMed Announces Raise Of $19.6 Million In Preferred Stock Financing 6/4/2014
Clinical Stage Biotech Trevi Therapeutics Brings In $25 Million Series B Financing 6/4/2014



//-->